Showing results (1-10 of 66) with videos related to

Sort By:
Pageof 7
Expert Opinion on Therapeutic Targets|February 19, 2020
FOXM1: a potential therapeutic target in human solid cancersSoheila Borhani, Andrei L Gartel
Frontiers in Oncology|August 12, 2021
FOXM1-AKT Positive Regulation Loop Provides Venetoclax Resistance in AMLMikhail S Chesnokov, Soheila Borhani, Marianna Halasi, et al.
Biochimica Et Biophysica Acta|May 28, 2008
Transcriptional inhibitors, p53 and apoptossAndrei L Gartel
Cancer Biology & Therapy|August 30, 2007
P21(WAF1/CIP1) may be a tumor suppressor after allAndrei L Gartel
Expert Opinion on Investigational Drugs|January 16, 2010
A new target for proteasome inhibitors: FoxM1Andrei L Gartel
Biofactors (Oxford, England)|May 19, 2009
p21(WAF1/CIP1) and cancer: a shifting paradigm?Andrei L Gartel
Current Topics in Medicinal Chemistry|January 28, 2012
Mechanisms of apoptosis induced by anticancer compounds in melanoma cellsAndrei L Gartel
Cancer Research|June 7, 2017
FOXM1 in Cancer: Interactions and VulnerabilitiesAndrei L Gartel
Cell Cycle (Georgetown, Tex.)|August 25, 2012
The oncogenic transcription factor FOXM1 and anticancer therapyAndrei L Gartel
Expert Opinion on Therapeutic Targets|May 16, 2008
FoxM1 inhibitors as potential anticancer drugsAndrei L Gartel
Pageof 7